Ibrutinib with Venetoclax in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia: A Phase II Study
Year: 2026
Type: article
Study design: Clinical Trial
Source: Blood Cancer Discovery
Authors: Mahesh Swaminathan, Alessandra Ferrajoli, Philip A. Thompson, Jan Burger, Gautam Borthakur, Koichi Takahashi, Zeev Estrov, Vanthana Bharathi, Alex Bataller, Tapan M. Kadia, Naveen Pemmaraju, Naval Daver, Elias Jabbour, Prithviraj Bose, Rashmi Kanagal-Shamanna, Keyur P. Patel, Sa A. Wang, Naveen Garg, Hyunsoo Hwang, Xuemei Wang, Wei Qiao, Xun Xu, Nichole Cruz, Ana Ayala, Sherry Pierce, William Plunkett, Deepa Sampath, Hagop M. Kantarjian, Michael J. Keating, Varsha Gandhi, William G. Wierda, Nitin Jain
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Award: G1468253849
OpenAlex ID: W7128690670